• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ACW

ACTINOGEN MEDICAL LIMITED

0.00% ! 2.0¢
Market Cap $63.54M  !

Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel... Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel therapy for neurological diseases associated with dysregulated brain cortisol. There is a strong association between cortisol and detrimental changes in the brain, affecting cognitive function, harm to brain cells and long term cognitive health.More

Corporate Spotlight

Actinogen is a neurotherapeutics developer realizing a revolutionary therapy so neurology patients and their families can live their best lives.
View the full Corporate Spotlight arrow Created with Sketch.

A new drug class and commercialisation for ACW

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ACW
Calm and Objective
13/06/25 53 15K
13/06/25 Last post  stormer Comments Created with Sketch.  53  Views Created with Sketch.  15K 
ACW
Estimating Actinogen's potential value - per Grok
11/06/25 3 930
11/06/25 Last post  stormer Comments Created with Sketch.  3  Views Created with Sketch.  930 
ACW 26/05/25 74 24K
26/05/25 Last post  Stealth101 Comments Created with Sketch.  74  Views Created with Sketch.  24K 
ACW
2025 will be the year
2 3 4
22/05/25 226 86K
22/05/25 Last post  Stealth101 Comments Created with Sketch.  226  Views Created with Sketch.  86K 
ACW 21/05/25 0 510
21/05/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  510 
ACW 20/05/25 5 1.9K
20/05/25 Last post  stormer Comments Created with Sketch.  5  Views Created with Sketch.  1.9K 
ACW 04/05/25 19 7.3K
04/05/25 Last post  Stealth101 Comments Created with Sketch.  19  Views Created with Sketch.  7.3K 
ACW 26/04/25 20 7.2K
26/04/25 Last post  Stealth101 Comments Created with Sketch.  20  Views Created with Sketch.  7.2K 
ACW 24/04/25 0 596
24/04/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  596 
ACW 23/04/25 20 7.2K
23/04/25 Last post  stormer Comments Created with Sketch.  20  Views Created with Sketch.  7.2K 
ACW
ACW Chart Thread
3 4 5
22/04/25 265 113K
22/04/25 Last post  NZ Trader Comments Created with Sketch.  265  Views Created with Sketch.  113K 
ACW 02/04/25 0 745
02/04/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  745 
ACW 27/03/25 0 786
27/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  786 
ACW 24/03/25 0 464
24/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  464 
ACW 24/03/25 0 353
24/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  353 
ACW 24/03/25 0 345
24/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  345 

See All Discussions arrow Created with Sketch.

Corporate Spotlight

Timeline

Ceasing to be a substantial holder
21 May 08:21
 
Actinogen CMO presents positive depression data at APA 2025
19 May 11:04
 
ACW Science Forum today - Preparing for commercialization
15 May 09:21
 
Actinogen March 2025 quarterly activity report & Appendix 4C
30 Apr 09:05
 
ACW Science Forum notice - Preparing for commercialization
24 Apr 08:28
 
Change in substantial holding
23 Apr 11:18
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
2.0¢
Change
0.000(0.00%)
Mkt cap ! $63.54M
Open High Low Value Volume
2.1¢ 2.1¢ 1.9¢ $128.6K 6.390M

Buyers (Bids)

No. Vol. Price($)
23 3337643 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 1075545 5
View Market Depth
Last trade - 15.57pm 13/06/2025 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.